Maxipime Lawsuits

Maxipime is an injectable antibiotic which is used for treatment of serious infections, such as pneumonia. Recent studies have raised concerns about an increased risk of death found among individuals treated with the antibiotic.

STATUS OF MAXIPIME LAWSUITS: The potential for legal claims are being reviewed and evaluated on behalf of individuals who have died while being treated with the antibiotic.

OVERVIEW: Maxipime (cefepime) is a beta-lactam antibiotic injection which is approved for treatment of a variety of serious infections, including:

Did You Know?

AT&T Data Breach Impacts Millions of Customers

More than 73 million customers of AT&T may have had their names, addresses, phone numbers, Social Security numbers and other information released on the dark web due to a massive AT&T data breach. Lawsuits are being pursued to obtain financial compensation.

Learn More
  • Pneumonia
  • Empiric therapy for febrile neutropenic patients
  • Urinary Tract Infections (UTI) including pyelonephritis
  • Skin Infections
  • Intra-Abdominal Infections

MAXIPIME DEATH SIDE EFFECTS: A 2007 meta-analysis published in the Lancet Infectious Diseases found that the death rate among those using cefepime (Maxipime) was higher than what was associated with other similar antibiotics. The study included data from 57 different clinical trials, comparing results from those treated with Maxipime injection to those treated with another beta-lactam antibiotic, either alone or with the addition of a non-beta-lactam antibiotic.

On November 14, 2007, the FDA issued an “early communication” regarding the possible risk of death associated with Maxipime and indicated that they would be reviewing safety data before reaching any conclusions about the need for additional warnings or regulatory actions.

On May 14, 2008, an update was issued by the FDA, since they had not completed their review of the Maxipime side effects within four months, as they had originally anticipated. They indicated that their review is ongoing as they still have not received and reviewed all of the study data they have requested.

Review a potential Maxipime Lawsuit with lawyers who are evaluating the possibility for claims.

While the FDA review of safety data, lawyers are evaluating the potential for Maxipime lawsuits on behalf of individuals who died while being treated with the antibiotic. Submit information about a potential case to have it reviewed and evaluated. If it appears that compensation may be available, you may be contacted by a Maxipime attorney.

2 Comments

  • BonnieJuly 1, 2022 at 11:08 am

    My 76 year old mother was given cefepime and has been on responsive for two weeks.

  • FDA is Continuing to Review Safety Concerns About Maxipime (cefepime) Death Risk — AboutLawsuits.comMay 15, 2008 at 2:38 am

    [...] an early communication issued last November about concerns that an injectable antibiotic known as Maxipime (cefepime), may increase the risk of death when compared to similar drugs. Although the FDA originally [...]

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Uber Driver Sexual Assaults and Misconduct Reports Must Be Disclosed in Lawsuit Discovery
Uber Driver Sexual Assaults and Misconduct Reports Must Be Disclosed in Lawsuit Discovery (Posted today)

A federal magistrate judge is forcing Uber to hand over potentially hundreds of thousands of incident files involving reports of passengers who suffered sexual misconduct or sexual assault at the hands of the rideshare service's drivers.

Abbott May Remove Infant Formula for Preemies Off the Market Due to Similac NEC Lawsuits
Abbott May Remove Infant Formula for Preemies Off the Market Due to Similac NEC Lawsuits (Posted yesterday)

Abbott Laboratories is considering removing Similac infant formula products designed for preterm babies from the market, as it faces hundreds of lawsuits claiming the products increase the risk of necrotizing enterocolitis, which puts newborns at a high risk of permanent injuries and death.

Information About Suboxone Dental Claims To Be Exchanged By Parties in MDL
Information About Suboxone Dental Claims To Be Exchanged By Parties in MDL (Posted 2 days ago)

A federal judge has ordered parties involved in Suboxone dental decay lawsuits to submit proposals for exchanging information that will guide the selection of representative bellwether claims for early test trials.